A Study to Compare the Efficacy and Safety of Umeclidinium/Vilanterol and Fluticasone Propionate/Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01817764 · COMPLETED
Trial details
- NCT number
- NCT01817764
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2013-10-01
- Enrollment
- 707
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.